NDC 49401-101 – Benlysta
Belimumab 120 mg/1.5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC49401-101
Product details
- Brand name
- Benlysta
- Generic name
- Belimumab
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125370
- Marketed since
- March 10, 2011
- Listing expires
- December 31, 2027
- Pharmacologic class
- B Lymphocyte Stimulator-specific Inhibitor
Active ingredients
- Belimumab 120 mg/1.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49401-101-01 | 1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL | Mar 10, 2011 |
Recalls mentioning this NDC
- D-0540-2025 Jul 30, 2025 · Class II
CGMP Deviations; potential temperature excursions due to transit delays